Total planned funding: $536,558,535
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $536,558,535 |
Organizational Types
NGO | $149,747,902 |
Private Contractor | $119,737,682 |
Host Country Government Agency | $76,877,438 |
Own Agency | $71,109,763 |
University | $49,859,428 |
Unknown | $38,999,078 |
Parastatal | $12,333,830 |
Other USG Agency | $8,032,716 |
FBO | $3,784,051 |
Implementing Agency | $3,226,452 |
Multi-lateral Agency | $2,850,195 |
Program Areas
Treatment | $147,640,198 |
Prevention | $113,654,136 |
Care | $106,686,739 |
Governance and Systems | $77,639,259 |
Management and Operations | $49,189,249 |
Testing | $41,748,954 |
Budget Codes
HTXS: Treatment: Adult Treatment | $119,045,657 |
HVMS: Management and Operations | $49,189,249 |
HVCT: Testing: HIV Testing and Counseling | $41,748,954 |
HKID: Care: Orphans and Vulnerable Children | $40,440,206 |
OHSS: Health Systems Strengthening | $38,711,697 |
HBHC: Care: Adult Care and Support | $38,362,493 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $33,845,742 |
HVSI: Strategic Information | $30,318,331 |
HVOP: Sexual Prevention: Other Sexual Prevention | $28,539,392 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,794,993 |
HVTB: Care: TB/HIV | $19,485,634 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $19,102,311 |
HTXD: Treatment: ARV Drugs | $17,742,371 |
PDTX: Treatment: Pediatric Treatment | $10,852,170 |
HLAB: Laboratory Infrastructure | $8,609,231 |
PDCS: Care: Pediatric Care and Support | $8,398,406 |
HMBL: Biomedical Prevention: Blood Safety | $6,411,235 |
HMIN: Biomedical Prevention: Injection Safety | $2,960,463 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$64,757,025
Countries/Regions
University of Washington:
$42,522,315
Countries/Regions
USG Aggregated Agencies:
$37,289,635
Countries/Regions